Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 6;5(4):e10032.
doi: 10.1371/journal.pone.0010032.

Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models

Affiliations

Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models

Kaitlin M Bratlie et al. PLoS One. .

Abstract

Background: Many materials are unsuitable for medical use because of poor biocompatibility. Recently, advances in the high throughput synthesis of biomaterials has significantly increased the number of potential biomaterials, however current biocompatibility analysis methods are slow and require histological analysis.

Methodology/principal findings: Here we develop rapid, non-invasive methods for in vivo quantification of the inflammatory response to implanted biomaterials. Materials were placed subcutaneously in an array format and monitored for host responses as per ISO 10993-6: 2001. Host cell activity in response to these materials was imaged kinetically, in vivo using fluorescent whole animal imaging. Data captured using whole animal imaging displayed similar temporal trends in cellular recruitment of phagocytes to the biomaterials compared to histological analysis.

Conclusions/significance: Histological analysis similarity validates this technique as a novel, rapid approach for screening biocompatibility of implanted materials. Through this technique there exists the possibility to rapidly screen large libraries of polymers in vivo.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Prof. Ralph Weissleder is a shareholder of VisEn Medical. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. Subcutaneous Injection arrays.
Three array formats used for injecting saline and polymers subcutaneously in mice where A is 30 µl, B is 50 µl, C is 70 µl, and D is 100 µl.
Figure 2
Figure 2. Time evolution of cathepsin activity in response to injected materials fluorescently imaged.
In vivo fluorescence imaging using ProSense 680 for cathepsin activity at various time points for a) saline, b) polystyrene, and c) alginate. The scale bar ranges 0–6×10−4 in fluorescence efficiency. The quantified fluorescence efficiencies of cathepsin activities are shown for d) polystyrene and e) alginate as the mean with standard deviation. Symbols represent data points and lines represent linear regressions.
Figure 3
Figure 3. Time evolution of macrophage response to injected materials fluorescently imaged.
In vivo fluorescence imaging of F4/80 pan macrophage antibody at various time points for a) saline, b) polystyrene, and c) alginate. The scale bar ranges 0–1.5×10−4 in fluorescence efficiency. The quantified fluorescence efficiency of F4/80 pan macrophage responses are shown for d) polystyrene and e) alginate as the mean with standard deviation. Symbols represent data points and lines represent linear regressions.
Figure 4
Figure 4. Histological scores of materials subcutaneously injected.
Histological scores of a) neutrophils, b) macrophages, and c) fibrosis determined for tissue excised at various time points with injections of saline, polystyrene, and alginate. Values shown are means with standard deviations.
Figure 5
Figure 5. H&E staining of representative sections subcutaneously injected.
Representative sections stained with H&E are shown for saline, polystyrene, and alginate at various time points (1, 3, 7, 14, 21, and 28 days post-injection). (Magnification 20×, scale bar = 100 µm).

References

    1. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452:580–589. - PMC - PubMed
    1. Weissleder R. Molecular Imaging in Cancer. Science. 2006;312:1168–1171. - PubMed
    1. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: The evolution of whole-body photonic imaging. Nature Biotechnology. 2005;23:313–320. - PubMed
    1. Weissleder R, Tung C-H, Mahmood T, Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescence probes. Nature Biotechnology. 1999;17:375–378. - PubMed
    1. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nature Medicine. 1997;3:177–182. - PubMed

Publication types